Leerink Partners Cuts Johnson & Johnson Price Target to $272 From $276
Leerink Partners maintained its Outperform rating on Johnson & Johnson, according to the report.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
Leerink Partners maintained its Outperform rating on Johnson & Johnson, according to the report.
Johnson & Johnson: Leerink Partners Cuts Target Price To $272 From $276